Anti-Human CD140a Recombinant Antibody(Olaratumab)
-
产品编号
YR1233
-
别名
科研级 Olaratumab ( 奥拉妥单抗 ), Anti-CD140a Recombinant Antibody, Research Grade Olaratumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Olaratumab ( 奥拉妥单抗 ), Anti-CD140a Recombinant Antibody, Research Grade Olaratumab |
| Catalog Number | YR1233 |
| Molecular Name | Olaratumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Olaratumab, sold under the brand name Lartruvo, is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha. It was removed from the United States and European Union markets in 2019, due to insufficient proof of its medical advantage (see below "Medical uses"). |
| CAS Number | 1024603-93-7 |
| Application | IF, IP, Neut, FuncS, ELISA, FCM |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Molecular Weight | 154 kDa |
| Target | CD140a[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
